Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Walewski

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Bone Marrow Transplantation|September 12, 2007
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplantB Nasilowska-Adamska, P Rzepecki, J Manko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational StudyJ M Zaucha, B Malkowski, S Chauvie, et al.
Bone Marrow Transplantation|July 10, 2002
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research GroupJ Czyz, A Hellmann, R Dziadziuszko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2024
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]T M Kim, M Taszner, S Novelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2024
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphomaT M Kim, M Taszner, S Novelli, et al.
Nature Immunology|November 28, 2024
Circulating tumor-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress anti-tumor immunity in patients with melanomaBenjamin Y Lu, Liliana E Lucca, Wesley Lewis, et al.
The New England Journal of Medicine|August 10, 2012
Treatment of older patients with mantle-cell lymphomaH C Kluin-Nelemans, E Hoster, O Hermine, et al.
G3 (Bethesda, Md.)|May 2, 2019
An Interscholastic Network To Generate LexA Enhancer Trap Lines in <i>Drosophila</i>Lutz Kockel, Catherine Griffin, Yaseen Ahmed, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bone Marrow Transplantation|September 12, 2007
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplantB Nasilowska-Adamska, P Rzepecki, J Manko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational StudyJ M Zaucha, B Malkowski, S Chauvie, et al.
Bone Marrow Transplantation|July 10, 2002
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research GroupJ Czyz, A Hellmann, R Dziadziuszko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2024
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]T M Kim, M Taszner, S Novelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2024
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphomaT M Kim, M Taszner, S Novelli, et al.
Nature Immunology|November 28, 2024
Circulating tumor-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress anti-tumor immunity in patients with melanomaBenjamin Y Lu, Liliana E Lucca, Wesley Lewis, et al.
The New England Journal of Medicine|August 10, 2012
Treatment of older patients with mantle-cell lymphomaH C Kluin-Nelemans, E Hoster, O Hermine, et al.
G3 (Bethesda, Md.)|May 2, 2019
An Interscholastic Network To Generate LexA Enhancer Trap Lines in <i>Drosophila</i>Lutz Kockel, Catherine Griffin, Yaseen Ahmed, et al.
Pageof 5